• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Taro International Ltd


    Drugs Disributed by Taro International Ltd

    Abacavir Lamivudine Taro
    Taro International Ltd
    RX
    not in the basket chart
    Multiple ingredients
    Abacavir Lamivudine Taro

    : Nucleoside & Guanosine Reverse Transcriptase Inhibitor. Lamivudine 300 mg, Abacavir 600 mg.
    TABS.:30. The recomm. dosage for adult.& child. over the age of 12 wt. at least 40 kg, is one tab., once dly. See lit.
    Indicated in antiretrovir. comb. ther. for the tmt. of (HIV) infect. in adult., adolesc. and child. weigh. at least 25 kg.
    C/I: Hypersens.

     

    Adatar Gel
    Taro International Ltd
    RX
    not in the basket chart
    Multiple ingredients
    Adatar Gel

    Retinoids. Adapalene 1 mg (0.1%), Benzoyl Peroxide 25 mg (2.5%).
    TOPICAL GEL:  30 g. For extern. use only.  Thin layer of gel evenly over acne (pimples) affected areas should be appl. once dly., at bdtme. on a clean dry skin.
    Eyes, lips, nostrils contact should be avoid. See lit.
    Cutaneous tmt. of acne vulgaris when comedones, papules and pustules are present.
    C/I
    : Hypersens.
    Women who are preg. or suspect. to be preg.

     

    Bortezomib Taro 3.5 mg
    Taro International Ltd
    RX
    not in the basket chart
    Bortezomib Taro 3.5 mg

    Proteasome Inhibitor. Bortezomib 3.5 mg.
    VIAL (Pwdr. for sol. for inj.): 1×3.5 mg. Dosage should be ajust. individ. See lit.
    Multiple Myeloma.
    Mantle Cell Lymphoma: For the tmt. of pts/ with mantle cell lymphoma who have received at least one prior ther.
    Bortezomib in comb. with rituximab, cyclophosphamide, doxorubicin & prednisone is indicated for the tmt. of adult pts. with previous. untreat. mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.
    C/I: Hypers. to bortezomib, boron or mannitol. Acute diffuse infiltrative pulmon. and pericard. dis. Intrathecal admin.

    Ilumya
    Taro International Ltd
    RX
    partial basket chart
    Ilumya

    Interleukin Inhibitor. Tildrakizumab 100 mg / 1 ml.
    PREFILL. SYRINGE:100 mg 100 mg SC inj. at wks. 0, and 4, every 12 wks. thereafter.
    Tmt. of adult. with mod.-sev. plaque psoriasis who are candidates for syst. ther. or photother.
    C/I: Hypersens. Clinic. import. active infect., e.g. active tubercul.

    Imatinib Taro
    Taro International Ltd
    RX
    full basket chart
    Imatinib Taro

    Protein Kinase Inhibitor. Imatinib 100 mg, 400 mg.
    FC Tabs. 60X100 mg, 30X400 mg. Ther. should be init. by a phys. exper. in tmt. of  hematological malign. and malign. sarcomas. See lit.

    Tmt of adlt. pts. and child. 3 years of age and above with Ph+ chron. myeloid leukaemia (Ph+ -CML) in chron. phase, accel phase or blast crisis.• Tmt of adlt. pts. with Kit (CD117) posit. unresect. and/or metast. malign. GI stromal tumours (GIST). • Adjuv. tmt of adlt. pts. follow. compl. gross resect. of Kit (CD117) posit. GIST.• Tmt of adlt. pts. with newly diagn. Philadelphia chrom. posit. ac. lymphoblastic leukemia (Ph+ ALL) integr. with chemother. • Tmt. of adlt. pts. with relapsed or refract. Ph+ ALL as monother. • Tmt. of adlt. pts. with unresect. dermatofibrosarcoma protuberans (DFSP) and adlt. pts. with recur. and/or metast. DFSP who are not elig. for surgery.• Tmt. of adlt. pts. with myelodysplastic/myeloproliferat. dis. (MDS/MPD) assoc. with PDGFR (platelet-derived growth factor receptor) gene re-arrangements. • Tmt. of adlt. pts. with hypereosinophilic syndr. (HES) and/or chron. eosinophilic leukaemia (CEL) who have the FIP1L1-PDGFRα fusion kinase (mutation. analysis or FISH demonstr. of CHIC2 allele delet.) and for pts. with HES and/or CEL who are FIP1L1- PDGFRα fusion kinase neg. • Tmt. of adlt. pt.s with aggress. syst. mastocytosis (ASM) without the D816V c-kit mutat.
    C/I: Hypersens.

    Lipodox Liposomal
    Taro International Ltd
    RX
    not in the basket chart
    Lipodox Liposomal

    Doxorubicin 2mg/ml.
    VIAL. (Liposome Concentrate for Sol. for IV infus.: 10, 25ml
    Dosage must be ajust. individ. according to the pt. indication and tolerability.
    1st or 2nd  line ther. of AIDS related Kaposis sarcoma in pts. with low CD 4 counts and extensive mucocutaneous or visceral dis.
    Tmt. of pts. with metastat. carcinoma of the ovary who are refract.to both paclitaxel and platinium-based chemother. regimens and who may also be refract. to topotecan. Refract. is defined as a pt. having progress. dis.while on tmt. or within 6 mnths. of complet. tmt.
    As monother.for pts. with metastat. breast cancer where there is an incr.card. risk.
    In comb. with bortezomib for the tmt. of progress. multiplemyeloma in pts. who have received at least one prior ther. and who have already undergone or are unsuit. for bone marrow transplant.
    C/I: Hypersens.
    Hypersens. peanut or soya.
    Pts. with AIDS-KS that may be effectively treated with local therapy or systemic alfa-interferon.

    CLOSE